Regulus Therapeutics | Attività Correnti

Current Assets Cambiamento Data
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Celldex Therapeutics USD 431.69M 185.76M 2023-12
Clal Biotechnology ILS 16.64M 4.52M 2022-12
Compugen USD 60.27M 9.13M 2023-09
CSL USD 9.26B 342.6M 2023-06
Gilead Sciences USD 16.45B 474M 2023-12
Grifols EUR 5.02B 210.6M 2023-09
Ionis Pharmaceuticals USD 2.64B 57.2M 2023-12
Ligand Pharmaceuticals USD 237.43M 16.56M 2023-12
Takeda JPY 2.46T 9.95B 2023-09



Regulus Therapeutics Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2024.